Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.
A Phase I/II, Observer-Blind, Randomized, Placebo-Controlled, Dose-Selection Study to Assess the Safety, Tolerability, and Immunogenicity of Hexavalent Group B Streptococcus Conjugate Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age (WOCBA) in the US and South Africa.
Sponsor: Inventprise Inc.
A PHASE1/PHASE2 clinical study on Group B Streptococcal Infections, this trial is ongoing. The trial is conducted by Inventprise Inc. and has accumulated 4 data snapshots since 2024. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
4 versions recorded-
Dec 2025 — Present [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Oct 2025 — Dec 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2025 — Oct 2025 [monthly]
Recruiting PHASE1/PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Feb 2025 [monthly]
Not Yet Recruiting PHASE1/PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Inventprise Inc.
- PATH
For direct contact, visit the study record on ClinicalTrials.gov .